Biodegradable Mg-Sr/Mg-Ag bilayer membranes enabling integrated osteogenic and antibacterial functions for guided bone regeneration.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42565011.
- Also identified by DOI 10.1016/j.bioactmat.2026.07.038 and PMC identifier 13446303.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biodegradable magnesium (Mg) alloys are promising candidates for guided bone regeneration (GBR) owing to their bone-matched elastic modulus and intrinsic bioactivity. However, simultaneously achieving mechanical robustness, degradation control, and multifunctional bioactivity in a single Mg-based membrane remains a major challenge. Herein, a magnesium-strontium/magnesium-silver (Mg-Sr/Mg-Ag) bilayer GBR membrane is constructed through rational design. Enabled by on-line heating rolling, the metallurgically bonded structure exhibits enhanced mechanical performance (flexural yield strength: 463 ± 9 MPa) while maintaining a stable corrosion rate. More importantly, the spatially resolved configuration enables distinct functional domains: the Sr-containing layer promotes osteogenesis at the bone interface, whereas the Ag-containing layer provides antibacterial protection at the soft-tissue side. The resulting membrane shows approximately 90% broad-spectrum antibacterial efficacy <i>in vitro</i> and significantly accelerates bone regeneration <i>in vivo</i>, with a bone volume fraction of 57.53 ± 4.82% at 8 weeks. Transcriptomic analysis of single alloy extracts suggests that Sr-containing cues are associated with Wnt-related osteogenic programs, whereas Ag-containing cues are associated with integrin-related cell adhesion and matrix-remodeling responses. These findings establish a metallurgically bonded bilayer Mg-alloy membrane that couples osteogenic ion delivery with antibacterial protection, providing a structurally stable and biologically programmed strategy for bone-soft tissue interface regeneration in GBR.